D. Rodríguez-Martínez

Drug Design and Discovery in Alzheimer’s Disease

Kenneth J. Witt, M. Z. Ahmad, Eric A. Owens, 2014 .

Atrial natriuretic factor in cirrhosis: relationship to renal function and hemodynamic changes.

J. Prieto, J. Quiroga, C. Fernández-Rodríguez, 1994, Journal of hepatology.

Research Strategies Developed for the Treatment of Alzheimer’s Disease. Reversible and Pseudo-Irreversible Inhibitors of Acetylcholinesterase: Structure-Activity Relationships and Drug Design

C. Martinez-Rincon, D. Rodríguez-Martínez, J. L. Pacheco-del-Cerro, 2014 .

Comparison of rifaximin and lactitol in the treatment of acute hepatic encephalopathy: results of a randomized, double-blind, double-dummy, controlled clinical trial.

J. Rodés, C. Fernández-Rodríguez, L. Rodrigo, 2003, Journal of hepatology.

Long-term effects of ursodeoxycholic acid in primary biliary cirrhosis: results of a double-blind controlled multicentric trial

J. Rodés, L. Rodrigo, D. Rodríguez-Martínez, 2000 .

Long-term effects of ursodeoxycholic acid in primary biliary cirrhosis: results of a double-blind controlled multicentric trial. UDCA-Cooperative Group from the Spanish Association for the Study of the Liver.

L. Rodrigo, D. Rodríguez-Martínez, A. Parés, 2000, Journal of hepatology.

Ascites adenosine deaminase activity is decreased in tuberculous ascites with low protein content.

C. Fernández-Rodríguez, D. Rodríguez-Martínez, L. M. Garcia-Vila, 1991, The American journal of gastroenterology.